Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination therapy in migraine: asset or issue?
Paolo Martelletti
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 10, pp. 995-996
Open Access | Times Cited: 19

Showing 19 citing articles:

Inflammatory complications of CGRP monoclonal antibodies: a case series
Jason C. Ray, Penelope J. Allen, Ann Bacsi, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 46
Therapeutic barriers for headache management: issues facing the global north and global south in 2024
William Wells-Gatnik, Paolo Martelletti
Expert Review of Neurotherapeutics (2025), pp. 1-3
Closed Access
Potential benefits and possible risks of CGRP-targeted multitherapy in migraine
Keiko Ihara, Tsubasa Takizawa, Narumi Watanabe, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 1-2, pp. 1-4
Open Access | Times Cited: 4
What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?
Marta Waliszewska‐Prosół, Doğa Vurallı, Paolo Martelletti
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Combining treatments for migraine prophylaxis: the state-of-the-art
Lanfranco Pellesi, David García‐Azorín, Eloísa Rubio‐Beltrán, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors
Raffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 10975-10975
Open Access | Times Cited: 14
Deprescribing in migraine
Paolo Martelletti, Michelangelo Luciani, Valerio Spuntarelli, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 6, pp. 623-625
Closed Access | Times Cited: 20
Atogepant and Sumatriptan: No Clinically Relevant Drug–Drug Interactions in a Randomized, Open-Label, Crossover Trial
Ramesh Boinpally, Abhijeet Jakate, Matthew Butler, et al.
Pain Management (2021) Vol. 12, Iss. 4, pp. 499-508
Open Access | Times Cited: 20
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Pain and Therapy (2021) Vol. 10, Iss. 1, pp. 637-650
Open Access | Times Cited: 17
Positioning the new drugs for migraine
Silvia Benemei, Enrico Bentivegna, Paolo Martelletti
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 1, pp. 1-3
Open Access | Times Cited: 12
Combining two CGRP inhibitors to treat migraine
Lanfranco Pellesi
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 9, pp. 1135-1136
Closed Access | Times Cited: 10
Safety and tolerability of preventive treatment options for chronic migraine
Amanda Tinsley, John F. Rothrock
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 12, pp. 1523-1533
Closed Access | Times Cited: 14
Comprehensive list of preventative migraine headache medications without significant drug–drug interactions
Jay Dave, Ian Hakkinen, Pengfei Zhang
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Treatment of migraine with monoclonal antibodies
José M. Serra López-Matencio, Ana Beatriz Gago‐Veiga, Manuel Gómez, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 707-716
Closed Access | Times Cited: 7
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
Toxins (2022) Vol. 15, Iss. 1, pp. 29-29
Open Access | Times Cited: 4
Non-interacting, Non-opioid, and Non-barbiturate Containing Acute Medication Combinations in Headache: A Pilot Combinatorics Approach Based on DrugBank Database
Victor Kaytser, Pengfei Zhang
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 4
Headache Management in Developing Countries
Aline Hajj, Marwan Akel, Jihan Safwan, et al.
Springer eBooks (2023), pp. 1-25
Closed Access
Lasmiditan
Simy Parikh
Headache (2022), pp. 83-95
Closed Access
Reaching the Nadir of Medication Overuse in Chronic Migraine
Dilara Onan, William Wells-Gatnik, Paolo Martelletti
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 22, pp. 14696-14696
Open Access
Page 1

Scroll to top